Neurovascular Devices | Market Insights | US | 2021
The COVID-19 pandemic will have a modest impact on the US market for neurovascular devices in the short term. Once the impact subsides, adoption of innovative devices as well as the ongoing expansion of dedicated infrastructure for neurovascular interventions will drive strong growth through 2029.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for stroke devices in the US across a 10-year period.
The US neurovascular device market will be impacted by the COVID-19 pandemic in the short term.
What factors will contribute to the market decline?
To what degree will the pandemic affect different procedures and devices?
How soon will procedure volumes, sales, and revenues recover?
The thrombectomy device market is seeing strong growth.
How does the update to treatment guidelines contribute to procedure growth?
How will the expansion of CSCs impact the market?
What are the dynamics surrounding the use of aspiration and stent retriever techniques?
Flow-diverting devices are contributing to growth in the embolization market.
What devices were recently introduced into the market?
How will the introduction of new flow-diverting devices affect the competitive dynamics of the segment that was previously monopolized by a single competitor?
How will adoption of flow-diverting devices impact the neurovascular embolization coil and coiling-assist device markets?
